Prequalified Vaccines
Displaying 151 - 200 of 264
| Prequalification Date | Vaccine Type | Commercial Name | Presentation | No. of doses | Manufacturer | Responsible NRA |
|---|---|---|---|---|---|---|
| Diphtheria-Tetanus-Pertussis (whole cell)-Hepatitis B-Haemophilus influenzae type b | None used on labelling for supply through UN agencies. Also marketed with labelled commercial name ComBE Five (Liquid). | Vial | 1 | Biological E. Limited | Central Drugs Standard Control Organization | |
| Diphtheria-Tetanus-Pertussis (whole cell)-Hepatitis B-Haemophilus influenzae type b | None used on labelling for supply through UN agencies. Also marketed with labelled commercial name ComBE Five (Liquid). | Vial | 2 | Biological E. Limited | Central Drugs Standard Control Organization | |
| Diphtheria-Tetanus-Pertussis (whole cell)-Hepatitis B-Haemophilus influenzae type b | None used on labelling for supply through UN agencies. Also marketed with labelled commercial name ComBE Five (Liquid). | Vial | 5 | Biological E. Limited | Central Drugs Standard Control Organization | |
| Diphtheria-Tetanus-Pertussis (whole cell)-Hepatitis B-Haemophilus influenzae type b | None used on labelling for supply through UN agencies. Also marketed with labelled commercial name ComBE Five (Liquid). | Vial | 10 | Biological E. Limited | Central Drugs Standard Control Organization | |
| Diphtheria-Tetanus-Pertussis (whole cell)-Hepatitis B-Haemophilus influenzae type b | None used on labelling for supply through UN agencies. Also marketed with labelled commercial name ComBE Five (Reconstituted). | Two vial set (active + active) | 1 | Biological E. Limited | Central Drugs Standard Control Organization | |
| Diphtheria-Tetanus-Pertussis (whole cell)-Hepatitis B-Haemophilus influenzae type b | None used on labelling for supply through UN agencies. Also marketed with labelled commercial name ComBE Five (Reconstituted). | Two vial set (active + active) | 10 | Biological E. Limited | Central Drugs Standard Control Organization | |
| Diphtheria-Tetanus-Pertussis (whole cell) | None used on labelling for supply through UN agencies. Also marketed with labelled commercial name TRIPVAC | Vial | 1 | Biological E. Limited | Central Drugs Standard Control Organization | |
| Diphtheria-Tetanus-Pertussis (whole cell) | None used on labelling for supply through UN agencies. Also marketed with labelled commercial name TRIPVAC | Vial | 10 | Biological E. Limited | Central Drugs Standard Control Organization | |
| Polio Vaccine - Oral (OPV) Monovalent Type 2 | ORAL MONOVALENT TYPE 2 POLIOMYELITIS VACCINE (mOPV2) | Vial | 20 | Sanofi Pasteur | Agence nationale de sécurité du médicament et des produits de santé | |
| Polio Vaccine - Oral (OPV) Trivalent | Oral Poliomyelitis Vaccines (Oral Drops) | Vial | 20 | PT Bio Farma (Persero) | National Agency of Drug and Food Control Indonesia | |
| Influenza, Pandemic (H5N1) | Pandemic Live Attenuated Vaccine | Sprayer | 1 | AstraZeneca Pharmaceuticals LP. | European Medicines Agency | |
| Influenza, Pandemic (H1N1) | Panenza | Vial | 10 | Sanofi Pasteur | Agence nationale de sécurité du médicament et des produits de santé | |
| Influenza, Pandemic (H1N1) | Panvax | Vial | 10 | Seqirus Limited | Therapeutic Goods Administration | |
| Diphtheria-Tetanus-Pertussis (whole cell)-Hepatitis B-Haemophilus influenzae type b | Pentabio | Vial | 5 | PT Bio Farma (Persero) | National Agency of Drug and Food Control Indonesia | |
| Diphtheria-Tetanus-Pertussis (whole cell)-Hepatitis B-Haemophilus influenzae type b | Pentabio | Vial | 10 | PT Bio Farma (Persero) | National Agency of Drug and Food Control Indonesia | |
| Polio Vaccine - Inactivated (IPV) | Picovax | Vial | 5 | AJ Vaccines A/S | Danish Medicines Agency | |
| Pneumococcal (conjugate) | PNEUMOSIL® | Vial | 1 | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | |
| Pneumococcal (conjugate) | PNEUMOSIL® | Vial | 5 | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | |
| Pneumococcal (conjugate) | PNEUMOSIL | Vial | 10 | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | |
| Polio Vaccine - Oral (OPV) Monovalent Type 1 | Polio Sabin Mono T1 | Vial | 10 | GlaxoSmithKline Biologicals SA | Federal Agency for Medicines and Health Products | |
| Polio Vaccine - Oral (OPV) Monovalent Type 1 | Polio Sabin Mono T1 | Vial | 20 | GlaxoSmithKline Biologicals SA | Federal Agency for Medicines and Health Products | |
| Polio Vaccine - Oral (OPV) Monovalent Type 3 | Polio Sabin Mono Three (oral) | Vial | 10 | GlaxoSmithKline Biologicals SA | Federal Agency for Medicines and Health Products | |
| Polio Vaccine - Oral (OPV) Monovalent Type 3 | Polio Sabin Mono Three (oral) | Vial | 20 | GlaxoSmithKline Biologicals SA | Federal Agency for Medicines and Health Products | |
| Polio Vaccine - Oral (OPV) Monovalent Type 2 | Polio Sabin Mono Two (oral) | Vial | 10 | GlaxoSmithKline Biologicals SA | Federal Agency for Medicines and Health Products | |
| Polio Vaccine - Oral (OPV) Monovalent Type 2 | Polio Sabin Mono Two (oral) | Vial | 20 | GlaxoSmithKline Biologicals SA | Federal Agency for Medicines and Health Products | |
| Polio Vaccine - Oral (OPV) Bivalent Types 1 and 3 | Polio Sabin One and Three | Vial | 10 | GlaxoSmithKline Biologicals SA | Federal Agency for Medicines and Health Products | |
| Polio Vaccine - Oral (OPV) Bivalent Types 1 and 3 | Polio Sabin One and Three | Vial | 20 | GlaxoSmithKline Biologicals SA | Federal Agency for Medicines and Health Products | |
| Polio Vaccine - Inactivated (IPV) | Poliomyelitis vaccine | Vial | 1 | Bilthoven Biologicals B.V. | Medicines Evaluation Board (MEB) | |
| Polio Vaccine - Novel Oral (nOPV) Type 2 | Polio Vaccine - Novel Oral (nOPV) Type 2 | Vial | 50 | PT Bio Farma (Persero) | National Agency of Drug and Food Control Indonesia | |
| Polio Vaccine - Inactivated (IPV) | Poliomyelitis Vaccine (Inactivated) | Vial | 1 | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | |
| Polio Vaccine - Inactivated (IPV) | Poliomyelitis Vaccine (Inactivated) | Vial | 2 | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | |
| Polio Vaccine - Inactivated (IPV) | Poliomyelitis Vaccine (Inactivated) | Vial | 5 | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | |
| Polio Vaccine - Inactivated (IPV) | Poliomyelitis Vaccine (Inactivated) | Vial | 10 | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | |
| Polio Vaccine - Oral (OPV) Bivalent Types 1 and 3 | Poliomyelitis Vaccine (live, oral attenuated, human Diploid Cell), type 1 and 3 | Vial | 20 | Beijing Institute of Biological Products Co., Ltd. | National Medical Products Administration | |
| Polio Vaccine - Oral (OPV) Bivalent Types 1 and 3 | Poliomyelitis Vaccine (Oral), Bivalent types 1 and 3 | Vial | 10 | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | |
| Polio Vaccine - Oral (OPV) Bivalent Types 1 and 3 | Poliomyelitis Vaccine (Oral), Bivalent types 1 and 3 | Vial | 20 | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | |
| Polio Vaccine - Inactivated Sabin (sIPV) | Poliomyelitis Vaccine (Vero Cell), Inactivated, Sabin Strains | Vial | 1 | Sinovac Biotech Co. Ltd | National Medical Products Administration | |
| Polio Vaccine - Inactivated Sabin (sIPV) | Poliomyelitis Vaccine (Vero Cell), Inactivated, Sabin Strains | Vial | 1 | Beijing Institute of Biological Products Co., Ltd. | National Medical Products Administration | |
| Polio Vaccine - Inactivated (IPV) | Poliomyelitis vaccine multidose | Vial | 5 | Bilthoven Biologicals B.V. | Medicines Evaluation Board (MEB) | |
| Polio Vaccine - Inactivated (IPV) | Poliomyelitis vaccine multidose | Vial | 10 | Bilthoven Biologicals B.V. | Medicines Evaluation Board (MEB) | |
| Polio Vaccine - Oral (OPV) Trivalent | Polioviral vaccine | Vial | 20 | Haffkine Bio Pharmaceutical Corporation Ltd | Central Drugs Standard Control Organization | |
| Pneumococcal (conjugate) | Prevenar 13 | Vial | 1 | Pfizer Europe MA EEIG | European Medicines Agency | |
| Pneumococcal (conjugate) | Prevenar 13 Multidose Vial | Vial | 4 | Pfizer Europe MA EEIG | European Medicines Agency | |
| Measles, Mumps and Rubella | Priorix | Vial | 1 | GlaxoSmithKline Biologicals SA | Federal Agency for Medicines and Health Products | |
| Measles, Mumps and Rubella | Priorix | Vial | 2 | GlaxoSmithKline Biologicals SA | Federal Agency for Medicines and Health Products | |
| Dengue Tetravalent (live, attenuated) | Qdenga | Two vial set (active + excipient) | 1 | Takeda GmbH. | European Medicines Agency | |
| Haemophilus influenzae type b | Quimi-Hib | Vial | 1 | Centro de Ingenieria Genetica y Biotecnologia | Centro para el Control Estatal de la Calidad de los Medicamentos | |
| Malaria | R21 Malaria | Vial | 1 | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | |
| Malaria | R21 Malaria | Vial | 2 | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization | |
| Rabies | Rabies Vaccine Inactivated (Freeze Dried)(RABIVAX-S) | Vial + Ampoule | 1 | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization |